Prof. Hamdy A. Azim HER2-positive Metastatic Breast Cancer Wrap-up 2/2

Prof. Hamdy A. Azim HER2-positive Early Breast Cancer Wrap-upПодробнее

Joanne Mortimer, MD: Functional imaging Of HER2-positive Metastatic Breast CancerПодробнее

Prof. Hamdy A. Azim HER2-positive Metastatic Breast Cancer Wrap-up 1/2Подробнее

Metastatic Breast Cancer: What You Need to KnowПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. SchwartzbergПодробнее

Moving the Needle in ER-Positive/HER2-Negative Metastatic Breast Cancer: Exploring SERD Strategie...Подробнее

ENHERTU Therapy: A Powerful New Cancer TreatmentПодробнее

Management of HER2 positive metastatic breast cancer treatment algorithmПодробнее

Metastatic Breast Cancer: HER2 PositiveПодробнее

Part 2-Management of metastatic breast cancer:luminal and her 2 positive tumors- Prof. Gilles FreyerПодробнее

HER2+ Breast Cancer Case Panel Discussion | 2022 Best of Breast ConferenceПодробнее

Dr. Rimawi on the Clinical Need for Immunotherapy in HER2-Positive Breast CancerПодробнее

Key challenge associated with the management of HR+/HER2- breast cancerПодробнее

Spotlight Poster Discussion: "Optimizing use of HER2 therapies in metastatic HER2+ breast..."Подробнее

Systemic Therapies Shown to be Effective in HER2-Positive Breast CancerПодробнее

T-DM1 as part of our standard of care with residual HER 2+ diseaseПодробнее

What EMERALD Phase III trial could mean for breast cancer patients | Virginia Kaklamani, MDПодробнее

Therapeutic landscape for patients with HER2-positive breast cancer with active brain metastasesПодробнее

Dr. Baselga Discusses the BOLERO Breast Cancer TrialsПодробнее